Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Immuron Limited ( (AU:IMC) ) is now available.
Immuron Limited has issued 877,440 ordinary shares without disclosure under Part 6D.2 of the Corporations Act, as per the notice given under section 708A(5)(e). The company confirms compliance with relevant provisions of the Corporations Act and states that there is no excluded information required to be disclosed. This issuance could potentially impact Immuron’s financial structure and investor relations by increasing the number of shares available in the market.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases. The company is listed on the Australian Securities Exchange (ASX) and NASDAQ, indicating its international market presence.
Average Trading Volume: 78,544
Technical Sentiment Signal: Sell
Current Market Cap: A$14.97M
See more insights into IMC stock on TipRanks’ Stock Analysis page.